12/20/2024 3:45 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2024 3:45 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 424B3 | |
11/22/2024 3:45 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 424B3 | |
11/06/2024 3:40 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 3:30 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2024 7:00 AM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2024 3:01 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 424B3 | |
|
08/16/2024 3:02 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 424B3 | |
08/15/2024 7:16 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 10-Q/A | |
08/15/2024 7:17 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 10-K/A | |
08/15/2024 7:18 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 10-Q/A | |
08/15/2024 7:19 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024 4:25 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 4:26 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form NT 10-Q | |
06/27/2024 2:04 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/26/2024 5:30 AM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 424B3 | |
03/26/2024 5:30 AM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 424B3 | |
03/25/2024 4:12 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 10-Q/A | |
03/25/2024 4:22 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 10-Q/A | |
03/25/2024 4:25 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 10-Q/A | |
03/25/2024 4:04 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 4:08 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 10-K/A | |
02/14/2024 2:32 PM | ARMISTICE CAPITAL, LLC (Filed by) Coeptis Therapeutics Holdings, Inc. (Subject) Coeptis Therapeutics Holdings, Inc. (Subject) Coeptis Therapeutics (Subject) Coeptis Therapeutics Holdings, Inc. (Subject)
| Form SC 13G | |
02/05/2024 4:15 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 424B3 | |
02/05/2024 4:17 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 424B3 | |
02/01/2024 4:28 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2024 7:14 PM | Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer) DeSilva Tara (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 11:27 AM | Coeptis Therapeutics Holdings, Inc. (Subject) Coeptis Therapeutics Holdings, Inc. (Subject) Coeptis Therapeutics (Subject) Coeptis Therapeutics Holdings, Inc. (Subject) Geller Avi (Filed by)
| Form SCHEDULE 13G | |
01/09/2024 4:30 PM | Cochran Christopher P. (Reporting) Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 4:30 PM | Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer) Mehalick David (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 4:31 PM | Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer) Salkind Gene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 4:32 PM | Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer) Coeptis Therapeutics (Issuer) Coeptis Therapeutics Holdings, Inc. (Issuer) Yerace Daniel Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 3:01 PM | Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics Holdings, Inc. (Filer) Coeptis Therapeutics (Filer) Coeptis Therapeutics Holdings, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |